Report of Proposed Sale of Securities (144)
June 12 2017 - 5:26PM
Edgar (US Regulatory)
OMB APPROVAL
|
OMB Number:
3235-0101
Expires: May
31, 2018
Estimated average burden
hours per response
1.00
|
SEC USE ONLY
|
DOCUMENT SEQUENCE NO.
|
CUSIP NUMBER
|
WORK LOCATION
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 144
NOTICE OF PROPOSED SALE OF SECURITIES
PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT OF 1933
|
ATTENTION:
|
Transmit
for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly
with a market maker.
|
1
(a)
NAME OF ISSUER
(Please type or print)
Creative Medical Technology Holdings, Inc.
|
(b)
IRS IDENT. NO.
87-0622284
|
(c)
S.E.C. FILE NO.
000-53500
|
1 (
d
) ADDRESS OF ISSUER STREET CITY STATE ZIP CODE
|
(e)
TELEPHONE NO.
|
2017 W Peoria Ave. Phoenix, AZ 85029
|
AREA CODE
602
|
NUMBER
680-7439
|
2
(a)
NAME
OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD
Creative Medical Health, Inc.
|
(b)
RELATIONSHIP
TO ISSUER
Parent Company
|
(c)
ADDRESS STREET CITY STATE ZIP CODE
2007 W Peoria Ave., Phoenix, AZ 85029
|
INSTRUCTION: The person filing
this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.
3
(a)
|
(b)
|
SEC USE ONLY
|
(c)
|
(d)
|
(e)
|
(f)
|
(g)
|
Title of the
Class of
Securities
To Be Sold
|
Name and Address of Each
Broker Through Whom the
Securities are to be Offered
or Each Market Maker
who is Acquiring the Securities
|
Broker-Dealer
File Number
|
Number of Shares
or Other Units
To Be Sold
(See instr. 3(c))
|
Aggregate
Market
Value
(See instr. 3(d))
|
Number of Shares
or Other Units
Outstanding
(See instr. 3(e))
|
Approximate
Date of Sale
(See instr. 3(f))
(MO. DAY YR.)
|
Name of Each
Securities
Exchange
(See instr. 3(g))
|
Common
|
JH Darbie & Co., Inc.
The Trump Building
40 Wall Street - 30th Floor
New York, NY 10005
|
|
750,000
|
$315,000
|
106,263,750
|
6/12/2017
|
OTCQB
|
INSTRUCTIONS:
|
|
|
|
|
|
1.
|
(a)
|
Name of issuer
|
3.
|
(a)
|
Title of the class of securities to be sold
|
|
(b)
|
Issuer’s I.R.S. Identification Number
|
|
(b)
|
Name and address of each broker through whom the securities are intended to be sold
|
|
(c)
|
Issuer’s S.E.C. file number, if any
|
|
(c)
|
Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
|
|
(d)
|
Issuer’s address, including zip code
|
|
(d)
|
Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
|
|
(e)
|
Issuer’s telephone number, including area code
|
|
(e)
|
Number of shares or other units of outstanding, as shown by the most the class outstanding, or if debt securities the face amount thereof recent report or statement published by the issuer
|
|
(f)
|
Approximate date on which the securities are to be sold
|
|
|
|
|
(g)
|
Name of each securities exchange, if any, on which the securities are intended to be sold
|
|
|
|
|
|
|
|
|
|
2.
|
(a)
|
Name of person for whose account the securities are to be sold
|
|
|
|
|
(b)
|
Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing)
|
|
|
|
|
(c)
|
Such person’s address, including zip code
|
|
|
|
Potential persons who are to respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control number.
|
SEC 1147 (08-07)
|
TABLE I
– SECURITIES TO BE SOLD
Furnish the following information with
respect to the acquisition of the securities to be sold
and with respect to the payment of all
or any part of the purchase price or other consideration therefor:
Title of
the Class
|
Date you Acquired
|
Nature of Acquisition Transaction
|
Name of Person from Whom Acquired
(If gift, also give date donor acquired)
|
Amount of Securities Acquired
|
Date of Payment
|
Nature of Payment
|
Common
|
5/18/16
|
Merger Transaction
|
Creative Medical Technology Holdings, Inc.
|
64,666,667
|
5/18/16
|
Stock exchange in merger transaction
|
|
INSTRUCTIONS:
|
If the securities were purchased and full payment therefor
was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given.
If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement
and state when the note or other obligation was discharged in full or the last installment paid.
|
TABLE II
– SECURITIES SOLD DURING THE PAST 3 MONTHS
Furnish the following information as
to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.
Name and Address of Seller
|
Title of Securities Sold
|
Date of Sale
|
Amount of
Securities Sold
|
Gross Proceeds
|
Creative Medical Health, Inc.
2007 W Peoria Ave
Phoenix, AZ 85029
|
Common Stock
|
5/18/17
6/2/17
6/2/17
6/5/17
6/5/17
|
1,400
3,500
2,200
2,500
2,800
|
$630
$1,400
$942
$775
$840
|
|
REMARKS:
|
Shares to be sold are control shares registered on Form
S-1 (SEC File No. 333-214741). The shares are being sold under a 10b5-1 plan dated May 15, 2017, with a starting date of May 10,
2017, and a maximum of 750,000 shares. Shares under the plan can be sold commencing June 12, 2017.
|
INSTRUCTIONS:
See the definition of “person” in paragraph (a)
of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to
all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are
required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
|
|
ATTENTION:
The person for whose account the securities to which
this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information
in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If
each person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by
signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation
as of the plan adoption or instruction date.
|
|
|
|
|
|
|
June 12, 2017
|
|
/s/ Timothy Warbington
|
DATE OF NOTICE
|
|
(SIGNATURE)
|
|
|
|
May 15, 2017
|
|
|
DATE OF PLAN ADOPTION OR GIVING OF
INSTRUCTION, IF RELYING ON RULE 10B5-1
|
|
The notice shall be signed by the
person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed.
Any copies not manually signed shall bear typed or printed signatures.
|
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)
|